lifestyle.massnews.com

Author: Vicore Pharma Holding

Vicore Pharma Announces Presentations at the 2026 American Thoracic Society International Conference

April 29, 2026
Vicore Pharma Completes Enrollment in the Phase 2b ASPIRE Trial of Buloxibutid in Idiopathic Pulmonary Fibrosis

April 22, 2026
Notice Of Annual General Meeting In Vicore Pharma Holding AB (PUBL)

April 1, 2026
Vicore Publishes the Annual Report for 2025

March 26, 2026
Vicore Pharma to Present at Upcoming Investor Conferences

March 9, 2026
Vicore Pharma Elevates Leadership Team Ahead of Key Clinical and Corporate Milestones

March 5, 2026
Year-End Report 2025

February 27, 2026
Vicore Pharma to Present at Upcoming Investor Conferences

February 26, 2026
Vicore Pharma to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference

February 18, 2026
Vicore Pharma to Present at the 44th Annual J.P. Morgan Healthcare Conference

January 7, 2026